Immunicum AB (publ) Announces New Issuance Date for Interim Report April – June 2019 and Corporate Update Event

NEXT STORY
Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares
PREV STORY
Curetis Reports Results of the Annual General Meeting Held on June 27, 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)

author_avatar
NASDAQ Market News

Data Updates from Ongoing MAGE-A10 Studies and MAGE-A4 Study to be presented at the European Society for Medical Oncology (ESMO) 2018 Congress

PHILADELPHIA and OXFORD, United Kingdom, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...

author_avatar
NASDAQ Market News

Teladoc Health Sees Daily Virtual Medical Visits Up 50% in Past Week

author_avatar
NASDAQ Market News